Clinical trial

Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain

NCT00709202

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-07-01

PhasePHASE2

Study timeline

Study start (unknown)2008-07-01Date precision: month

Registry last updated2019-01-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Schizoaffective Disorderunresolved

Schizophreniform Disorderunresolved

Bipolar I Disorderunresolved

Bipolar IIunresolved

Bipolar NOS(Not Otherwise Specified)unresolved

Psychotic Disorder Not Otherwise Specifiedunresolved

Autism Spectrum Disorderunresolved

Interventions

BetahistineDRUG

Placebo Oral TabletDRUG

Sponsors & collaborators

Nathan Kline Institute for Psychiatric Researchlead sponsor

Stanley Medical Research Institutecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00709202 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.